학술논문

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Document Type
Review
Source
In: The Lancet Regional Health - Europe. (The Lancet Regional Health - Europe, June 2023, 29)
Subject
Language
English
ISSN
26667762